advertisement

---

Berdeaux G 5

Showing records 1 to 5 | Display all abstracts from Berdeaux G

47834 Ocular discomfort, compliance and intra-ocular pressure (IOP) control in patients treated for glaucoma
Lafuma A; Robert J; Berdeaux G
Value in Health 2011; 14: A502

---

47832 Economic outcomes of glaucoma treatment with prostaglandin eye drops preserved with polyquad(registered trademark) instead of benzalkonium chloride in Germany
Gerlier L; Lamotte M; Lorenz K; Berdeaux G; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A503

---

47833 Longer term patient benefits of polyquad(registered trademark) preservative instead of benzalkonium chloride in prostaglandin eye drops: A microsimulation model in ocular hypertension and open-angle glaucoma
Gerlier L; Lamotte M; Berdeaux G; Verboven Y; Pfeiffer N
Value in Health 2011; 14: A502

---

47841 Cost-effectiveness of the ex-press glaucoma filtration device in France
de Jong L; Lafuma A; Clement O; Aguade AS; Berdeaux G
Value in Health 2011; 14: A250-A251

---

47839 Cost-effectiveness of the ex-press glaucoma filtration device in the Netherlands
de Jong L; Lafuma A; Aguade AS; Clement O; Berdeaux G
Value in Health 2011; 14: A250

---